Katherine Smith
Queen Mary University of London
9 Papers
36 Citations
Katherine Smith is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Varenicline & Smoking cessation. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Safety and efficacy of pazopanib therapy prior to planned nephrectomy in metastatic clear cell renal cancer
Thomas Powles,Naveed Sarwar,Andrew Stockdale,Shah-Jalal Sarker,Ekaterini Boleti,Andrew Protheroe,Robert Jones,Simon Chowdhury,John Peters,Grenville Oades,Tim O'Brien,Mark Sullivan,Michael Aitchison,Luis Beltran,Daniel C Worth,Katherine Smith,Constance Michel,Giorgia Trevisan,Elizabeth Harvey-Jones,Akhila Wimalasingham,Anju Sahdev,Charlotte Ackerman,Simon J. Crabb +22 more
TL;DR: Nephrectomy after upfront pazopanib therapy could be performed safely and was associated with good outcomes in patients with intermediate-risk metastatic clear cell renal cancer.
Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
TL;DR: Predictive biomarkers are needed to go beyond PD-L1 expression, which is showing inconsistent results across trials.
38
High-aspect-ratio silica nozzle fabrication for nano-emitter electrospray applications
L. Wang,Robert Stevens,Adnan Malik,Peter Rockett,Mark D. Paine,Paul Adkin,Scott Martyn,Katherine Smith,John P. W. Stark,Peter J. Dobson +9 more
TL;DR: In this article, an investigation of silicon deep etch by DRIE was performed and achieved a depth greater than 200mm for 10-mm diameter channels, and the result showed that a thin gold film with low surface energy would offer the desired level of hydrophobic performance and be sufficiently robust for most micronozzle applications.
19
A full voltage-controlled nanoelectrospray system and its steady characteristic analysed by empirically equivalent circuit method
TL;DR: In this paper, a pure voltage-controlled nanoelectrospray system with low flow rates of nL/min was developed, and a linear correlation between current and voltage was clearly identified; this can be attributed directly to the unforced electrosprays where the spray properties are uniquely dictated by the voltage.
16
Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir
Miriam Samuel,Daniel Bradshaw,Melissa Perry,Sum Yee Chan,Rageshri Dhairyawan,L Byrne,Katherine Smith,Judith Zhou,Charlotte Eve Short,Claire Naftalin,Ngozi Offodile,Sundhiya Mandalia,Sherie Roedling,Rimi Shah,Gary Brook,Mary Poulton,Mette Rodgers,Liat Sarner,H Noble,P Hay,Jane Anderson,Macky Natha,David Hawkins,Graham P. Taylor,Annemiek de Ruiter +24 more
TL;DR: The data suggest that atazanavir is well tolerated and can be safely prescribed as a component of combination antiretroviral therapy in pregnancy.